Gabelli Funds LLC Nevro Corp Transaction History

Gabelli Funds LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $163,400 - $310,680	-4,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $239,800 - $368,240	4,000 New	4,000 $289,000
Q3 2019 Nov 01, 2019	SELL	$61.52 - $91.1 $6.58 Million - $9.75 Million	-107,000 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$58.04 - $66.99 $2.06 Million - $2.38 Million	-35,500 Reduced 24.91%	107,000 $6.94 Million
Q1 2019 May 02, 2019	SELL	$35.52 - $62.62 $532,800 - $939,300	-15,000 Reduced 9.52%	142,500 $8.91 Million
Q4 2018 Jan 30, 2019	BUY	$35.43 - $56.29 $425,160 - $675,480	12,000 Added 8.25%	157,500 $6.13 Million
Q3 2018 Nov 02, 2018	BUY	$44.22 - $75.47 $4.44 Million - $7.57 Million	100,298 Added 221.89%	145,500 $8.29 Million
Q2 2018 Aug 10, 2018	BUY	$72.38 - $92.5 $1.86 Million - $2.38 Million	25,702 Added 131.81%	45,202 $3.61 Million
Q1 2018 May 09, 2018	SELL	$69.46 - $88.57 $208,379 - $265,710	-3,000 Reduced 13.33%	19,500 $1.69 Million
Q4 2017 Feb 02, 2018	BUY	$65.94 - $93.31 $1.48 Million - $2.1 Million	22,500	22,500 $1.55 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $131M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.